⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

SYK

Stryker Corporation

Healthcare · Medical Devices

307.15USD

+0.0700 (+0.02%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on SYK.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$3.55▼$3.68014
Next quarter$5.12▼$5.18110
Current year$14.95▼$14.98113
Next year$16.66▼$16.72014

Recent quarters

Beat in 3 of the last 4

QuarterEstimateActualSurprise
2026-06-30$3.49$3.69+0.20 (+5.8%)
2026-03-31$2.98$2.6-0.38 (-12.9%)
2025-12-31$4.4$4.47+0.07 (+1.7%)
2025-09-30$3.13$3.19+0.06 (+1.9%)

Wall Street coverage

394 ratings from 48 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
BTIGMaintainedBuy$358 $316Oct 12, 2026
Truist SecuritiesMaintainedHold$340 $310Oct 7, 2026
BarclaysInitiatedOverweight$375Oct 7, 2026
StifelMaintainedBuy$360 $330Sep 30, 2026
TD CowenMaintainedHold$355 $298Sep 22, 2026
Canaccord GenuityMaintainedBuy$400 $385Sep 18, 2026
CitigroupMaintainedBuy$399 $360Sep 10, 2026
Wells FargoMaintainedOverweight$418 $348Sep 9, 2026
Wolfe ResearchDowngraded from OutperformPeer Perform—Aug 13, 2026
CitizensMaintainedMarket Outperform$440 $400Aug 3, 2026
RBC CapitalMaintainedOutperform$435 $420Jul 31, 2026
JP MorganMaintainedOverweight$400 $350Jul 31, 2026
Piper SandlerMaintainedOverweight$420 $390Jul 31, 2026
Truist SecuritiesMaintainedHold$330 $340Jul 31, 2026
BTIGMaintainedBuy$371 $358Jul 31, 2026
BMO CapitalInitiated from Market PerformOutperform$369Jul 9, 2026
Evercore ISI GroupMaintainedOutperform$355 $350Jul 6, 2026
Leerink PartnersMaintainedOutperform$410 $407Jun 5, 2026
Truist SecuritiesReiteratedHold$380 $330May 4, 2026
BarclaysMaintainedOverweight$469 $394May 4, 2026
Canaccord GenuityMaintainedBuy$435 $400May 1, 2026
JP MorganMaintainedOverweight$445 $400May 1, 2026
Evercore ISI GroupMaintainedOutperform$365 $355May 1, 2026
Wells FargoMaintainedOverweight$456 $418May 1, 2026
NeedhamMaintainedBuy$454 $418May 1, 2026

Insider transactions

8 filings from 2 insiders · 14 buy / 6 sell over 6m

Officers and directors of SYK, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Wells Preston WendellOfficer, VP, Chief Financial OfficerOther109——Sep 24, 2026
Wells Preston WendellOfficer, VP, Chief Financial OfficerOther962——Sep 22, 2026
Wells Preston WendellOfficer, VP, Chief Financial OfficerOther1.8k——Jul 17, 2026
BRAINERD MARY KDirectorBuyindirect18$225.19$4kNov 22, 2022
BRAINERD MARY KDirectorBuyindirect3$185.65$557Jun 12, 2020
BRAINERD MARY KDirectorBuyindirect36$193.21$7kMay 12, 2020
BRAINERD MARY KDirectorBuyindirect11$221.03$2kSep 12, 2019
BRAINERD MARY KDirectorBuyindirect63$202.21$13kJun 26, 2019

Analyst Notes

Sign in to write

No analyst notes on SYK yet.

Analyst Ratings

26 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current815600Buy1.93
1 mo ago715600Buy1.96
2 mo ago715600Buy1.96
3 mo ago716500Buy1.93
Price target$362.62$298.00 – $465.00
+18.1% to target

Top voices on SYK

Members whose judged calls on SYK have played out most reliably.

No settled calls on SYK yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice